EWTXHealthcareMid-Cap
Edgewise Therapeutics, Inc. Insider Trading Activity
Every SEC Form 4 insider transaction reported for Edgewise Therapeutics, Inc. (EWTX), sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud Research Team · SEC Form 4 & insider trading data analysts
Last updated:
Quick Answer
Are EWTX insiders buying or selling?
Edgewise Therapeutics, Inc. insiders reported 16 open-market buys ($79.0M) and 69 sells ($44.6M) across 85 Form 4 filings — a net buying position of $34.5M.
Source: SEC EDGAR Form 4
Key Statistics (as of Jul 2, 2026)
Total Form 4 filings
85
SEC EDGAR
Insider filers
14
Insider buys (16)
$79.0M
Insider sells (69)
$44.6M
Insider sentiment
Net buyingNet insider flow of $34.5M in net buying.
Recent EWTX insider transactions
| Date | Insider | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jul 2, 2026 | Alan J Russell | Chief Scientific Officer | Sale | 200.0K | $39.41 | $7.9M |
| May 5, 2026 | Joanne M. Donovan | CMO | Sale | 55.2K | $37.88 | $2.1M |
| Apr 2, 2026 | Joanne M. Donovan | CMO | Sale | 28.7K | $32.31 | $926.1K |
| Mar 31, 2026 | Joanne M. Donovan | CMO | Sale | 21.3K | $32.12 | $685.3K |
| Mar 30, 2026 | Joanne M. Donovan | CMO | Sale | 16.4K | $30.98 | $506.7K |
| Jan 23, 2026 | Badreddin Edris | Director | Sale | 115.5K | $29.44 | $3.4M |
| Nov 13, 2025 | Alan J Russell | Chief Scientific Officer | Sale | 100.0K | $21.12 | $2.1M |
| Nov 13, 2025 | Jonathan C Fox | Director | Purchase | 10.7K | $18.64 | $199.4K |
| Aug 28, 2025 | Alan J Russell | Chief Scientific Officer | Sale | 100.0K | $14.60 | $1.5M |
| Aug 14, 2025 | John R Moore | General Counsel | Sale | 2.1K | $13.39 | $28.1K |
| Aug 14, 2025 | Behrad Derakhshan | Chief Business Officer | Sale | 2.5K | $13.39 | $33.4K |
| Aug 14, 2025 | Michael R Carruthers | Chief Financial Officer | Sale | 1.4K | $13.39 | $19.1K |
| Aug 14, 2025 | Alan J Russell | Chief Scientific Officer | Sale | 1.9K | $13.39 | $25.5K |
| Aug 14, 2025 | Kevin Koch | President and CEO | Sale | 8.0K | $13.39 | $106.8K |
| Aug 14, 2025 | Joanne M. Donovan | CMO | Sale | 2.9K | $13.39 | $38.3K |
| May 8, 2025 | Alan J Russell | Chief Scientific Officer | Sale | 1.6K | $16.45 | $25.5K |
| May 8, 2025 | John R Moore | General Counsel | Sale | 1.9K | $16.45 | $31.8K |
| May 8, 2025 | Kevin Koch | President and CEO | Sale | 4.3K | $16.45 | $70.4K |
| May 8, 2025 | Joanne M. Donovan | CMO | Sale | 5.2K | $16.45 | $85.3K |
| May 8, 2025 | Behrad Derakhshan | Chief Business Officer | Sale | 1.7K | $16.45 | $27.8K |
| May 8, 2025 | Michael R Carruthers | Chief Financial Officer | Sale | 1.3K | $16.45 | $21.6K |
| Apr 4, 2025 | Peter A. Thompson | Director, 10% Owner | Purchase | 496.8K | $20.13 | $10.0M |
| Apr 4, 2025 | ORBIMED ADVISORS LLC | Director, 10% Owner | Purchase | 496.8K | $20.13 | $10.0M |
| Mar 11, 2025 | Alan J Russell | Chief Scientific Officer | Sale | 200 | $30.02 | $6.0K |
| Mar 11, 2025 | Kevin Koch | President and CEO | Sale | 100 | $30.00 | $3.0K |
Showing the 25 most recent of 85 Form 4 filings for Edgewise Therapeutics, Inc..
Most active EWTX insiders
- Alan J Russell22 filings
- John R Moore16 filings
- Joanne M. Donovan10 filings
- Behrad Derakhshan7 filings
- Kevin Koch6 filings
Ask anything about EWTX insider activity
Use Trabud's AI agent to query Edgewise Therapeutics, Inc.'s Form 4 history in plain English — "Show me EWTX CEO purchases this year" or compare it against any other ticker.
Open the AI agentEWTX insider trading FAQ
Are Edgewise Therapeutics, Inc. insiders buying or selling?
Across 85 SEC Form 4 filings, Edgewise Therapeutics, Inc. (EWTX) insiders reported 16 open-market purchases totaling $79.0M and 69 sales totaling $44.6M. That is a net buying position of $34.5M.
How many insiders trade EWTX stock?
14 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for Edgewise Therapeutics, Inc.. The most recent filing was accepted on Jul 2, 2026.
Where does Trabud get EWTX insider trading data?
All EWTX insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.
Looking for another company? Browse all tracked companies.